Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer
Stopped early · Phase 2 · Has a placebo group
Conditions studied: Anal Cancer, Carcinoma of the Appendix, Colorectal Cancer, Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Gastric Cancer, Gastrointestinal Carcinoid Tumor, Liver Cancer, Nausea and Vomiting, Pancreatic Cancer, Primary Peritoneal Cavity Cancer, Small Intestine Cancer
In brief
RATIONALE: Palonosetron hydrochloride may prevent nausea and vomiting caused by radiation therapy. It is not yet known whether palonosetron hydrochloride is more effective than a placebo in preventing nausea and vomiting. PURPOSE: This randomized phase II trial is studying the side effects of palonosetron hydrochloride and to see how well it works in preventing nausea and vomiting caused by radiation therapy in patients with primary abdominal cancer.
Key facts
- Study ID
- NCT00903396
- Run by
- Alliance for Clinical Trials in Oncology
- People needed
- 7
- Starts
- 2009-09-01
- Expected to finish
- 2013-05-01
- Last updated by the study team
- 2017-11-24
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Mayo Clinic - Jacksonville — Jacksonville, Florida, United States
- Trinity Cancer Center at Trinity Medical Center - 7th Street Campus — Moline, Illinois, United States
- Study site — Moline, Illinois, United States
- Elkhart Clinic, LLC — Elkhart, Indiana, United States
- Michiana Hematology-Oncology, PC - Elkhart — Elkhart, Indiana, United States
- Elkhart General Hospital — Elkhart, Indiana, United States
- Howard Community Hospital — Kokomo, Indiana, United States
- Center for Cancer Therapy at LaPorte Hospital and Health Services — La Porte, Indiana, United States
- Michiana Hematology-Oncology, PC - South Bend — Mishawaka, Indiana, United States
- Saint Joseph Regional Medical Center — Mishawaka, Indiana, United States
- Michiana Hematology Oncology PC - Plymouth — Plymouth, Indiana, United States
- CCOP - Northern Indiana CR Consortium — South Bend, Indiana, United States
- Memorial Hospital of South Bend — South Bend, Indiana, United States
- South Bend Clinic — South Bend, Indiana, United States
- Michiana Hematology Oncology PC - La Porte — Westville, Indiana, United States
- Study site — Bettendorf, Iowa, United States
- Siouxland Hematology-Oncology Associates, LLP — Sioux City, Iowa, United States
- Mercy Medical Center - Sioux City — Sioux City, Iowa, United States
- St. Luke's Regional Medical Center — Sioux City, Iowa, United States
- Wesley Medical Center — Wichita, Kansas, United States
- Michiana Hematology Oncology PC - Niles — Niles, Michigan, United States
- Lakeland Regional Cancer Care Center - St. Joseph — Saint Joseph, Michigan, United States
- Lakeside Cancer Specialists, PLLC — Saint Joseph, Michigan, United States
- Duluth Clinic Cancer Center - Duluth — Duluth, Minnesota, United States
- Mayo Clinic Scottsdale — Scottsdale, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.